THE BRD INHIBITOR OTX015 IS ACTIVE IN PRE CLINICAL B CELL LYMPHOMA MODELS AND AFFECTS RELEVANT PATHOGENETIC PATHWAYS: 114M Boi,P Bonetti,E Gaudio, E Bernasconi,A Rinaldi,I Kwee,A Stathis,G Stussi,M Ponzoni,M Tibiletti, E Riveiro, P Herait,G Inghirami,E Zucca,F BertoniHematological Oncology(2013)引用 1|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要